Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

References for PMC Articles for PubMed (Select 22876296)

1.

Checking consistency in mixed treatment comparison meta-analysis.

Dias S, Welton NJ, Caldwell DM, Ades AE.

Stat Med. 2010 Mar 30;29(7-8):932-44. doi: 10.1002/sim.3767.

PMID:
20213715
2.

[Meta-analyses uncertain basis for first choice antidepressive agents].

Melander H.

Lakartidningen. 2009 Apr 1-7;106(14):1030-1. Swedish. No abstract available.

PMID:
19485039
3.

Depression in adults: drug and physical treatments.

Barbui C, Butler R, Cipriani A, Geddes J, Hatcher S.

BMJ Clin Evid. 2007 Jun 15;2007. pii: 1003.

4.

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis.

Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C.

Lancet. 2009 Feb 28;373(9665):746-58. doi: 10.1016/S0140-6736(09)60046-5. Review.

PMID:
19185342
5.

Exploring uncertainty in cost-effectiveness analysis.

Claxton K.

Pharmacoeconomics. 2008;26(9):781-98.

PMID:
18767898
6.

Use of indirect and mixed treatment comparisons for technology assessment.

Sutton A, Ades AE, Cooper N, Abrams K.

Pharmacoeconomics. 2008;26(9):753-67. Review.

PMID:
18767896
7.

Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis.

Omori IM, Watanabe N, Nakagawa A, Akechi T, Cipriani A, Barbui C, McGuire H, Churchill R, Furukawa TA; Meta-Analysis of New Generation Antidepressants (MANGA) Study Group.

J Psychopharmacol. 2009 Jul;23(5):539-50. doi: 10.1177/0269881108089876. Epub 2008 Jun 18. Review.

PMID:
18562407
8.

Observational studies of depression in primary care: what do we know?

Gilchrist G, Gunn J.

BMC Fam Pract. 2007 May 11;8:28. Review.

9.

Cost of depression in Europe.

Sobocki P, Jönsson B, Angst J, Rehnberg C.

J Ment Health Policy Econ. 2006 Jun;9(2):87-98.

PMID:
17007486
10.

Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials.

Machado M, Iskedjian M, Ruiz I, Einarson TR.

Curr Med Res Opin. 2006 Sep;22(9):1825-37.

PMID:
16968586
11.

Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.

McGrath PJ, Stewart JW, Fava M, Trivedi MH, Wisniewski SR, Nierenberg AA, Thase ME, Davis L, Biggs MM, Shores-Wilson K, Luther JF, Niederehe G, Warden D, Rush AJ.

Am J Psychiatry. 2006 Sep;163(9):1531-41; quiz 1666.

PMID:
16946177
12.

A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report.

Nierenberg AA, Fava M, Trivedi MH, Wisniewski SR, Thase ME, McGrath PJ, Alpert JE, Warden D, Luther JF, Niederehe G, Lebowitz B, Shores-Wilson K, Rush AJ.

Am J Psychiatry. 2006 Sep;163(9):1519-30; quiz 1665.

PMID:
16946176
13.

The mission is remission: health economic consequences of achieving full remission with antidepressant treatment for depression.

Sobocki P, Ekman M, Agren H, Runeson B, Jönsson B.

Int J Clin Pract. 2006 Jul;60(7):791-8.

PMID:
16846399
14.

Cost of depression: effect of adherence and treatment response.

von Knorring L, Akerblad AC, Bengtsson F, Carlsson A, Ekselius L.

Eur Psychiatry. 2006 Sep;21(6):349-54. Epub 2006 Jun 13.

PMID:
16777385
15.

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, Ritz L, Biggs MM, Warden D, Luther JF, Shores-Wilson K, Niederehe G, Fava M; STAR*D Study Team.

N Engl J Med. 2006 Mar 23;354(12):1231-42.

16.

Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder.

Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS.

Ann Intern Med. 2005 Sep 20;143(6):415-26. Review.

PMID:
16172440
18.

Mood disorders and suicide.

Nierenberg AA, Gray SM, Grandin LD.

J Clin Psychiatry. 2001;62 Suppl 25:27-30. Review.

PMID:
11765092
19.
20.

Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments.

Kennedy SH, Lam RW, Cohen NL, Ravindran AV; CANMAT Depression Work Group.

Can J Psychiatry. 2001 Jun;46 Suppl 1:38S-58S. Review.

PMID:
11441771
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk